The Endocannabinoid System in Obesity and Type 2 Diabetes

Diabetologia - Germany
doi 10.1007/s00125-008-1048-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Rehashing Endocannabinoid Antagonists: Can We Selectively Target the Periphery to Safely Treat Obesity and Type 2 Diabetes?

Journal of Clinical Investigation
Medicine
2010English

Obesity and Type 2 Diabetes Mellitus

Internal Medicine: Open Access
2014English

Obesity and Type 2 Diabetes Mellitus

Integrative Obesity and Diabetes
2018English

The Oral Microflora in Obesity and Type-2 Diabetes

Journal of Oral Microbiology
Infectious DiseasesMicrobiologyDentistry
2012English

Epigenetics in Human Obesity and Type 2 Diabetes

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Obesity and Diabetes Type 2-Related Complications

International Journal of Diabetes & Metabolic Disorders
2017English

11?-Hydroxysteroid Dehydrogenase Type 1 in Obesity and Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Antidiabetic Drugs of Type 2 Diabetes and Obesity

2016English

The Immune System's Involvement in Obesity-Driven Type 2 Diabetes

Seminars in Immunology
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy